# Rheumatoid Arthritis Research and Therapies

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the pathogenesis, classification, management, and treatment outcomes of rheumatoid arthritis. It covers topics such as the role of inflammation, biological and disease-modifying therapies, autoantibodies, joint inflammation, cytokines, cardiovascular risk, synoviocytes, and the genetic contribution to the disease. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10200 |
| Works | 855 |

## Topic papers all

Showing 15 of 855.

- [2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative](https://scholariq.org/papers/2010-rheumatoid-arthritis-classification-criteria-an-american-college-of-2/)
- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic/)
- [Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus](https://scholariq.org/papers/derivation-and-validation-of-the-systemic-lupus-international-collaborating/)
- [2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative](https://scholariq.org/papers/2010-rheumatoid-arthritis-classification-criteria-an-american-college-of/)
- [Derivation of the sledai. A disease activity index for lupus patients](https://scholariq.org/papers/derivation-of-the-sledai-a-disease-activity-index-for-lupus-patients/)
- [Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis](https://scholariq.org/papers/comparison-of-upper-gastrointestinal-toxicity-of-rofecoxib-and-naproxen-in/)
- [Classification criteria for psoriatic arthritis: Development of new criteria from a large international study](https://scholariq.org/papers/classification-criteria-for-psoriatic-arthritis-development-of-new-criteria-from/)
- [Evolving concepts of rheumatoid arthritis](https://scholariq.org/papers/evolving-concepts-of-rheumatoid-arthritis/)
- [The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study](https://scholariq.org/papers/the-global-burden-of-hip-and-knee-osteoarthritis-estimates-from-the-global/)
- [Defining the clinical course of multiple sclerosis](https://scholariq.org/papers/defining-the-clinical-course-of-multiple-sclerosis/)
- [American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee](https://scholariq.org/papers/american-college-of-rheumatology-2012-recommendations-for-the-use-of/)
- [Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/infliximab-and-methotrexate-in-the-treatment-of-rheumatoid-arthritis/)
- [Rheumatoid arthritis](https://scholariq.org/papers/rheumatoid-arthritis/)
- [SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX](https://scholariq.org/papers/systemic-lupus-erythematosus-disease-activity-index/)
- [American college of rheumatology preliminary definition of improvement in rheumatoid arthritis](https://scholariq.org/papers/american-college-of-rheumatology-preliminary-definition-of-improvement-in/)

## Topic primary papers

Showing 15 of 268.

- [2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative](https://scholariq.org/papers/2010-rheumatoid-arthritis-classification-criteria-an-american-college-of-2/)
- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic/)
- [2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative](https://scholariq.org/papers/2010-rheumatoid-arthritis-classification-criteria-an-american-college-of/)
- [Evolving concepts of rheumatoid arthritis](https://scholariq.org/papers/evolving-concepts-of-rheumatoid-arthritis/)
- [Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/infliximab-and-methotrexate-in-the-treatment-of-rheumatoid-arthritis/)
- [Rheumatoid arthritis](https://scholariq.org/papers/rheumatoid-arthritis/)
- [American college of rheumatology preliminary definition of improvement in rheumatoid arthritis](https://scholariq.org/papers/american-college-of-rheumatology-preliminary-definition-of-improvement-in/)
- [2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis](https://scholariq.org/papers/2015-american-college-of-rheumatology-guideline-for-the-treatment-of-rheumatoid/)
- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-2/)
- [Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States](https://scholariq.org/papers/estimates-of-the-prevalence-of-arthritis-and-selected-musculoskeletal-disorders/)
- [Rheumatoid arthritis](https://scholariq.org/papers/rheumatoid-arthritis-2/)
- [Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies](https://scholariq.org/papers/anti-tnf-antibody-therapy-in-rheumatoid-arthritis-and-the-risk-of-serious/)
- [Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial](https://scholariq.org/papers/infliximab-chimeric-anti-tumour-necrosis-factor-monoclonal-antibody-versus/)
- [Diagnosis and Management of Rheumatoid Arthritis](https://scholariq.org/papers/diagnosis-and-management-of-rheumatoid-arthritis/)
- [Treating rheumatoid arthritis to target: recommendations of an international task force](https://scholariq.org/papers/treating-rheumatoid-arthritis-to-target-recommendations-of-an-international-task/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.